Tip of the iceberg? The emergence of antibiotic-resistant organisms in the IBD population.
Inflammatory bowel disease (IBD) patients have risk factors for acquisition of antibiotic-resistant organisms such as MRSA. In a recent study, we have shown a rising prevalence of MRSA infection among hospitalized IBD patients. This population is at increased risk of infection and its associated mortality. These findings underscore the need for infection control measures in the hospital setting.
Mount Sinai Hospital Centre for Inflammatory Bowel Disease, University of Toronto, Toronto, Canada. geoff.nguyen@utoronto.ca
Geoffrey C
GC
Nguyen
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology / Q000401:mortality; D024901:Drug Resistance, Multiple, Bacterial; D006760:Hospitalization; D006801:Humans; D017053:Infection Control / Q000379:methods; D015212:Inflammatory Bowel Diseases / Q000150:complications*; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification*; D013203:Staphylococcal Infections / Q000453:epidemiology* / Q000382:microbiology* / Q000401:mortality
D000900:Anti-Bacterial Agents